KING LUTHER CAPITAL MANAGEMENT CORP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
KING LUTHER CAPITAL MANAGEMENT CORP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$6,681,847
+12.1%
65,5340.0%0.03%
+6.5%
Q1 2023$5,958,351
+139.3%
65,5340.0%0.03%
+121.4%
Q4 2022$2,489,637
+51.2%
65,5340.0%0.01%
+40.0%
Q3 2022$1,647,000
-17.3%
65,5340.0%0.01%
-9.1%
Q2 2022$1,992,000
-11.3%
65,534
-4.4%
0.01%0.0%
Q1 2022$2,245,000
+8.5%
68,534
-12.6%
0.01%
+22.2%
Q4 2021$2,069,000
-82.1%
78,459
-31.9%
0.01%
-84.2%
Q3 2021$11,590,000
-26.8%
115,196
+3.0%
0.06%
-26.0%
Q2 2021$15,833,000
+42.2%
111,871
+0.2%
0.08%
+28.3%
Q1 2021$11,133,000
-9.0%
111,661
+12.8%
0.06%
-13.0%
Q4 2020$12,233,000
+45.4%
98,956
+14.5%
0.07%
+30.2%
Q3 2020$8,416,000
-34.3%
86,390
+5.2%
0.05%
-40.4%
Q2 2020$12,816,000
+36.1%
82,146
+26.0%
0.09%
+8.5%
Q1 2020$9,414,000
-29.4%
65,2210.0%0.08%
-7.9%
Q4 2019$13,333,000
+55.4%
65,221
-39.0%
0.09%
+43.5%
Q3 2019$8,582,000
-8.6%
106,882
+7.4%
0.06%
-10.1%
Q2 2019$9,392,000
+11.1%
99,545
+0.6%
0.07%
+6.2%
Q1 2019$8,457,000
+52.4%
98,9450.0%0.06%
+32.7%
Q4 2018$5,551,000
-27.4%
98,945
+5.8%
0.05%
-15.5%
Q3 2018$7,646,000
+133.8%
93,5160.0%0.06%
+114.8%
Q2 2018$3,270,000
+151.2%
93,516
+47.3%
0.03%
+145.5%
Q1 2018$1,302,000
-20.3%
63,495
+10.1%
0.01%
-15.4%
Q4 2017$1,633,000
-8.9%
57,6580.0%0.01%
-18.8%
Q3 2017$1,793,000
+1.2%
57,658
+3.0%
0.02%0.0%
Q2 2017$1,771,000
+39.7%
55,9820.0%0.02%
+33.3%
Q1 2017$1,268,00055,9820.01%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders